Unknown

Dataset Information

0

A real-time PCR assay for DNA-methylation using methylation-specific blockers.


ABSTRACT: DNA methylation-based biomarkers have been discovered that could potentially be used for the diagnosis of cancer by detection of circulating, tumor-derived DNA in bodily fluids. Any methylation detection assay that would be applied to these samples must be capable of detecting small amounts of tumor DNA in the presence of background normal DNA. We have developed a real-time PCR assay, called HeavyMethyl, that is well suited for this application. HeavyMethyl uses methylation-specific oligonucleotide blockers and a methylation-specific probe to achieve methylation-specific amplification and detection. We tested the assays on unmethylated and artificially methylated DNA in order to determine the limit of detection. After careful optimization, our glutathione-S-transferase pi1 and Calcitonin assays can amplify as little as 30 and 60 pg of methylated DNA, respectively, and neither assay amplifies unmethylated DNA. The Calcitonin assay showed a highly significant methylation difference between normal colon and colon adenocarcinomas, and methylation was also detected in serum DNA from colon cancer patients. These assays show that HeavyMethyl technology can be successfully employed for the analysis of very low concentrations of methylated DNA, e.g. in serum of patients with tumors.

SUBMITTER: Cottrell SE 

PROVIDER: S-EPMC373310 | biostudies-literature | 2004

REPOSITORIES: biostudies-literature

altmetric image

Publications

A real-time PCR assay for DNA-methylation using methylation-specific blockers.

Cottrell Susan E SE   Distler Jürgen J   Goodman Nancy S NS   Mooney Suzanne H SH   Kluth Antje A   Olek Alexander A   Schwope Ina I   Tetzner Reimo R   Ziebarth Heike H   Berlin Kurt K  

Nucleic acids research 20040113 1


DNA methylation-based biomarkers have been discovered that could potentially be used for the diagnosis of cancer by detection of circulating, tumor-derived DNA in bodily fluids. Any methylation detection assay that would be applied to these samples must be capable of detecting small amounts of tumor DNA in the presence of background normal DNA. We have developed a real-time PCR assay, called HeavyMethyl, that is well suited for this application. HeavyMethyl uses methylation-specific oligonucleot  ...[more]

Similar Datasets

| S-EPMC497581 | biostudies-other
| S-EPMC2438202 | biostudies-literature
| S-EPMC120584 | biostudies-literature
| S-EPMC1081263 | biostudies-literature
| S-EPMC1853271 | biostudies-literature
| S-EPMC38513 | biostudies-other
| S-EPMC3237602 | biostudies-literature
| S-EPMC1393095 | biostudies-literature
| S-EPMC5500521 | biostudies-literature
| S-EPMC179856 | biostudies-literature